Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker

NCT00847990 is registered in ClinicalTrials.gov with Sequenom, Inc. as lead sponsor.

NCT NCT00847990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00847990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Lead sponsor
Sequenom, Inc.
Phase
Observational
Overall status
Completed
Start date
March 31, 2009
Completion date
August 31, 2011
Enrollment
5,000 (estimated)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

down syndrome, edwards syndrome